⌘K

Login Start Free

Home/Filings/4/0001087294-26-000002

4//SEC Filing

Krogulski Kenneth 4

Accession 0001087294-26-000002

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:03 PM ET

Size

36.6 KB

Accession

0001087294-26-000002

Insider Transaction Report

Form 4

Period: 2025-12-01

CUMBERLAND PHARMACEUTICALS INCCPIX

Krogulski Kenneth

Director

Transactions

Small Acquisition
Common Stock
2025-12-01$2.36/sh+124$293→ 294,746 total
Small Acquisition
Common Stock
2025-12-02$2.24/sh+124$278→ 294,870 total
Small Acquisition
Common Stock
2025-12-03$2.25/sh+124$279→ 294,994 total
Small Acquisition
Common Stock
2025-12-04$2.27/sh+124$281→ 295,118 total
Small Acquisition
Common Stock
2025-12-05$2.34/sh+124$290→ 295,242 total
Small Acquisition
Common Stock
2025-12-08$2.40/sh+104$250→ 295,346 total
Small Acquisition
Common Stock
2025-12-09$2.32/sh+104$241→ 295,450 total
Small Acquisition
Common Stock
2025-12-10$2.60/sh+104$270→ 295,554 total
Small Acquisition
Common Stock
2025-12-11$2.56/sh+104$266→ 295,658 total
Small Acquisition
Common Stock
2025-12-12$2.50/sh+104$260→ 295,762 total
Small Acquisition
Common Stock
2025-12-15$2.82/sh+104$293→ 295,866 total
Small Acquisition
Common Stock
2025-12-16$3.27/sh+104$340→ 295,970 total
Small Acquisition
Common Stock
2025-12-17$3.65/sh+67$245→ 296,037 total
Small Acquisition
Common Stock
2025-12-18$4.19/sh+67$281→ 296,104 total
Small Acquisition
Common Stock
2025-12-19$4.19/sh+52$218→ 296,156 total
Small Acquisition
Common Stock
2025-12-22$4.32/sh+50$216→ 296,206 total
Small Acquisition
Common Stock
2025-12-23$4.13/sh+54$223→ 296,260 total
Small Acquisition
Common Stock
2025-12-24$4.26/sh+54$230→ 296,314 total
Small Acquisition
Common Stock
2025-12-26$4.21/sh+54$227→ 296,368 total
Small Acquisition
Common Stock
2025-12-29$4.01/sh+54$217→ 296,422 total
Small Acquisition
Common Stock
2025-12-30$3.94/sh+54$213→ 296,476 total
Small Acquisition
Common Stock
2025-12-31$3.91/sh+62$242→ 296,538 total

Footnotes (1)

[F1]The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

Documents

1 file

4
wk-form4_1767736989.xmlPrimary
FORM 4

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001695580

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 5:03 PM ET
Size: 36.6 KB

View on SEC.gov